These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 26599282)
1. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma. Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282 [TBL] [Abstract][Full Text] [Related]
2. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma. Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513 [TBL] [Abstract][Full Text] [Related]
3. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma. Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma. Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215 [TBL] [Abstract][Full Text] [Related]
5. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma. Laba P; Wang J; Zhang J BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799 [TBL] [Abstract][Full Text] [Related]
6. Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma. Kawakami I; Yoshino H; Fukumoto W; Tamai M; Okamura S; Osako Y; Sakaguchi T; Inoguchi S; Matsushita R; Yamada Y; Tatarano S; Nakagawa M; Enokida H Biochem Biophys Res Commun; 2022 Jun; 611():99-106. PubMed ID: 35487063 [TBL] [Abstract][Full Text] [Related]
7. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890 [TBL] [Abstract][Full Text] [Related]
8. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma. NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma. Xie C; Yiu W; Mo Y Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144 [TBL] [Abstract][Full Text] [Related]
10. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma. Oz Atalay F; Aytac Vuruskan B; Vuruskan H APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774 [TBL] [Abstract][Full Text] [Related]
12. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Lu X; Wan F; Zhang H; Shi G; Ye D Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048 [TBL] [Abstract][Full Text] [Related]
13. Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma. Fu H; Liu Y; Xu L; Chang Y; Zhou L; Zhang W; Yang Y; Xu J Medicine (Baltimore); 2016 Apr; 95(17):e3225. PubMed ID: 27124015 [TBL] [Abstract][Full Text] [Related]
14. Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy. Qin C; Liu Z; Yuan Y; Zhang X; Li H; Zhang C; Xu T; Wang X Mol Med Rep; 2014 Mar; 9(3):851-6. PubMed ID: 24425288 [TBL] [Abstract][Full Text] [Related]
15. Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma. Xie H; Zhu Y; An H; Wang H; Zhu Y; Fu H; Wang Z; Fu Q; Xu J; Ye D Oncotarget; 2016 May; 7(22):32723-30. PubMed ID: 27092876 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211 [TBL] [Abstract][Full Text] [Related]
17. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis. Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063 [TBL] [Abstract][Full Text] [Related]
18. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729 [TBL] [Abstract][Full Text] [Related]
19. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma. Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma. Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]